These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


479 related items for PubMed ID: 9477980

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Early photocoagulation in patients with either type I or type II diabetes.
    Ferris F.
    Trans Am Ophthalmol Soc; 1996; 94():505-37. PubMed ID: 8981711
    [Abstract] [Full Text] [Related]

  • 3. Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Factors Associated with Vision and Edema Outcomes.
    Bressler SB, Beaulieu WT, Glassman AR, Gross JG, Melia M, Chen E, Pavlica MR, Jampol LM, Diabetic Retinopathy Clinical Research Network.
    Ophthalmology; 2018 Nov; 125(11):1776-1783. PubMed ID: 29980333
    [Abstract] [Full Text] [Related]

  • 4. Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study.
    Sjølie AK, Stephenson J, Aldington S, Kohner E, Janka H, Stevens L, Fuller J.
    Ophthalmology; 1997 Feb; 104(2):252-60. PubMed ID: 9052629
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pars plana vitrectomy in the Early Treatment Diabetic Retinopathy Study. ETDRS report number 17. The Early Treatment Diabetic Retinopathy Study Research Group.
    Flynn HW, Chew EY, Simons BD, Barton FB, Remaley NA, Ferris FL.
    Ophthalmology; 1992 Sep; 99(9):1351-7. PubMed ID: 1407968
    [Abstract] [Full Text] [Related]

  • 7. High prevalence in Malawi of sight-threatening retinopathy and visual impairment caused by diabetes: identification of population-specific targets for intervention.
    Burgess PI, Allain TJ, García-Fiñana M, Beare NA, Msukwa G, Harding SP.
    Diabet Med; 2014 Dec; 31(12):1643-50. PubMed ID: 24823871
    [Abstract] [Full Text] [Related]

  • 8. What may be gained from standard photocoagulation during early worsening of diabetic retinopathy? An observational study in type-1 diabetic patients after tightening of glycaemic control.
    Chantelau E.
    Diabetes Metab; 2001 Jun; 27(3):366-71. PubMed ID: 11431602
    [Abstract] [Full Text] [Related]

  • 9. Causes of severe visual loss in the early treatment diabetic retinopathy study: ETDRS report no. 24. Early Treatment Diabetic Retinopathy Study Research Group.
    Fong DS, Ferris FL, Davis MD, Chew EY.
    Am J Ophthalmol; 1999 Feb; 127(2):137-41. PubMed ID: 10030553
    [Abstract] [Full Text] [Related]

  • 10. Changes in visual impairment prevalence by period of diagnosis of diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy.
    Klein R, Lee KE, Knudtson MD, Gangnon RE, Klein BE.
    Ophthalmology; 2009 Oct; 116(10):1937-42. PubMed ID: 19616855
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Serum Lipids and Proliferative Diabetic Retinopathy and Macular Edema in Persons With Long-term Type 1 Diabetes Mellitus: The Wisconsin Epidemiologic Study of Diabetic Retinopathy.
    Klein BE, Myers CE, Howard KP, Klein R.
    JAMA Ophthalmol; 2015 May; 133(5):503-10. PubMed ID: 25502808
    [Abstract] [Full Text] [Related]

  • 15. Association Between Vessel Density and Visual Acuity in Patients With Diabetic Retinopathy and Poorly Controlled Type 1 Diabetes.
    Dupas B, Minvielle W, Bonnin S, Couturier A, Erginay A, Massin P, Gaudric A, Tadayoni R.
    JAMA Ophthalmol; 2018 Jul 01; 136(7):721-728. PubMed ID: 29800967
    [Abstract] [Full Text] [Related]

  • 16.
    Cowie CC, Casagrande SS, Menke A, Cissell MA, Eberhardt MS, Meigs JB, Gregg EW, Knowler WC, Barrett-Connor E, Becker DJ, Brancati FL, Boyko EJ, Herman WH, Howard BV, Narayan KMV, Rewers M, Fradkin JE, Klein R, Klein BEK.
    ; 2018 08 01. PubMed ID: 33651534
    [Abstract] [Full Text] [Related]

  • 17. Oxidized Low-Density Lipoprotein and the Incidence of Proliferative Diabetic Retinopathy and Clinically Significant Macular Edema Determined From Fundus Photographs.
    Klein R, Myers CE, Lee KE, Paterson AD, Cruickshanks KJ, Tsai MY, Gangnon RE, Klein BE.
    JAMA Ophthalmol; 2015 Sep 01; 133(9):1054-61. PubMed ID: 26181138
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Lipid-Lowering Medications Are Associated with Lower Risk of Retinopathy and Ophthalmic Interventions among United States Patients with Diabetes.
    Vail D, Callaway NF, Ludwig CA, Saroj N, Moshfeghi DM.
    Am J Ophthalmol; 2019 Nov 01; 207():378-384. PubMed ID: 31194953
    [Abstract] [Full Text] [Related]

  • 20. Ten-year incidence of visual loss in a diabetic population.
    Moss SE, Klein R, Klein BE.
    Ophthalmology; 1994 Jun 01; 101(6):1061-70. PubMed ID: 8008348
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.